Granules India Limited has informed the Exchange regarding a press release dated September 11, 2020, titled "Granules Receives USFDA approval for complex, Attention Deficit Hyperactivity Disorder (ADHD) Drug".
Press Release Sep 11 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Later from Granules India
- Press Release Sep 25 2020
- Press Release Oct 22 2020
- Press Release Dec 03 2020
- Press Release Jan 13 2021
- Press Release Feb 01 2021
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India